COMMUNIQUÉS West-GlobeNewswire

Iktos announces the appointment of Avirup Bose as Chief Business Officer
18/01/2024
Iktos announces the appointment of Avirup Bose as Chief Business Officer Paris (France), 18 January, 2024 – Iktos, a company specialized in Artificial Intelligence for new drug design, announces the appointment of [...]
ONWARD® Announces Start of HemON NL Clinical Study
18/01/2024
HemON NL is evaluating the use of ARC-IM® Therapy to address hemodynamic instability after spinal cord injury EINDHOVEN, the Netherlands, Jan. 18, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the [...]
argenx Announces Approval of VYVDURA® (efgartigimod alfa and hyaluronidase-qvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis
18/01/2024
Availability of VYVGART ® and self-administered VYVDURA demonstrates continued commitment to providing more choice and flexibility for gMG patients in Japan Jan. 18, 2024, 7:00 AM CET Amsterdam, the Netherlands – argenx [...]
NeuroSigma Announces FDA Clearance of its Second-Generation Monarch eTNS System for Treating Pediatric ADHD
18/01/2024
LOS ANGELES, Jan. 17, 2024 (GLOBE NEWSWIRE) -- NeuroSigma today announced that the U.S. Food and Drug Administration (FDA) cleared use of NeuroSigma’s second-generation Monarch eTNS System for treating pediatric [...]
Junshi Biosciences Announces JAMA Publication of Results from NEOTORCH, a Randomized Phase 3 Trial of Perioperative Toripalimab plus Chemotherapy for Patients with Resectable Non-Small Cell Lung Cancer
18/01/2024
SHANGHAI, China, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, [...]
Immatics Announces Pricing of $175 Million Public Offering
18/01/2024
Houston, Texas and Tuebingen, Germany, January 17, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer [...]
Lowell Farms Inc. Announces Termination of the Zabala Road Lease
18/01/2024
SALINAS, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (the “Company”) (CSE: LOWL; OTCQX: LOWLF), a California-born cannabis company with advanced production capabilities including extraction, [...]
MedBright AI Investments Inc. Responds to OTC Markets Request on Recent Promotional Activity
18/01/2024
VANCOUVER, British Columbia, Jan. 17, 2024 (GLOBE NEWSWIRE) -- MEDBRIGHT AI INVESTMENTS INC. (CSE: MBAI; OTCQB: MBAIF; FSE: 1V7) (“ MedBright ” or the “ Company ”) announces that it has been requested by OTC Markets [...]
Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries
17/01/2024
Cytek’s Cutting-Edge Spectral Flow Cytometry Technology, Specialized Staff, Tools and Solutions Set New Benchmarks for Cell Analysis FREMONT, Calif. and BARCELONA, Spain, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Cytek [...]
StateHouse Announces Update to Board of Directors
17/01/2024
SAN DIEGO and TORONTO, Jan. 17, 2024 (GLOBE NEWSWIRE) -- StateHouse Holdings Inc . (“StateHouse” or the “Company”) (CSE: STHZ) (OTCQB: STHZF), a California-focused, vertically integrated cannabis company, today [...]
Sanofi: Information concerning the total number of voting rights and shares - December 2023
17/01/2024
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Decembre 2023
17/01/2024
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
NGM Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference
17/01/2024
SOUTH SAN FRANCISCO, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today [...]
Apollomics to Participate in a Fireside Chat at the B. Riley Securities’ 2024 Virtual Oncology Conference
17/01/2024
FOSTER CITY, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (“Apollomics” or the “Company”), a clinical-stage biopharmaceutical company developing medicines to address difficult-to-treat cancers, today [...]
Aravive, Inc. to Delist from The Nasdaq Stock Market
17/01/2024
HOUSTON, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, “the Company”), announced today that the Company intends to voluntarily terminate the listing of its common stock on the Nasdaq Global Select [...]
Nyxoah Announces 2024 Strategic Priorities
17/01/2024
Nyxoah Announces 2024 Strategic Priorities Mont-Saint-Guibert, Belgium – January 17, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company [...]
Nyxoah Annonce ses Priorités Stratégiques pour 2024
17/01/2024
Nyxoah Annonce ses Priorités Stratégiques pour 2024 Mont-Saint-Guibert, Belgique – 17 janvier 2024, 22h05 CET / 16h05 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq : NYXH) (« Nyxoah » ou la « Société ») opère dans le [...]
R1 RCM Completes Acquisition of Acclara, Providence’s Modular Services Business
17/01/2024
Company Enters 10-Year Agreement to Provide Comprehensive Revenue Cycle Management Services to Providence Company to Release Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Outlook on February 27 [...]
Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update
17/01/2024
First patient dosed in company’s second clinical program with initial data expected in second half of 2024 Cash runway extended into second half of 2025 with clinical trials on track CAMBRIDGE, Mass., Jan. 17, 2024 ( [...]

Pages